VSTM · NASDAQ · Biotechnology

Verastem (VSTM)

Markets AVMAPKI FAKZYNJA and develops small-molecule drugs for RAS/MAPK-driven cancers.

$7.98
vs last close−0.39 (−4.70%)
  1. Verastem Stock Skyrockets 121% in 3 Months: Here Is Why

    Zacks Investment ResearchMarket move